DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

European Medicines Agency

2017 年 10 月 16 日 8:00 上午 - 2017 年 10 月 17 日 4:00 下午

30 Churchill Place, Canary Wharf, London, E14 5EU, United Kingdom

DIA/EFGCP/EMA Conference on How to Optimise Children’s Access to Innovative Medicines

United in the goal of increasing the availability of new medicines to paediatric patients, how can we leverage examples from past successes to overcome future barriers?

Session 4 HOW ARE CHILDREN, CARERS AND FAMILIES CONTRIBUTING TO THE DECISION MAKING?

Session Chair(s)

Katie  Rizvi

Katie Rizvi

Founder, Little People Association & Temerarii Club

The Romanian Community of Cancer Survivor Adolescents and Young Adults, Romania

The session will focus on both the technical and practical aspects of involving children and young persons’ advisory groups in decision making processes whether at regulatory, health technology assessment (HTA) or medicines research and development (R&D) levels. Discussions will include the point of view and expectations of different stakeholders.

Speaker(s)

Nathalie  Bere, MPH

Engagement with young patients

Nathalie Bere, MPH

European Medicines Agency, Netherlands

Patient Engagement

Yvonne  Schmidt, PhD

Yvonne Schmidt, PhD

Federal Joint Committee (G-BA), Germany

Scientific Advisor, Pharmaceuticals Department

Pamela  Dicks, PhD

Active Involvement of Children and Young People In Clinical Research Design

Pamela Dicks, PhD

Scottish Children's Research Network (ScotCRN), United Kingdom

Network Manager

Anna  Sherriffs

Anna Sherriffs

Young Persons’ Advisory Group (YPAG) Scotland, United Kingdom

Young Patient Advocate

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。